{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T21:16:28Z","timestamp":1770930988029,"version":"3.50.1"},"reference-count":69,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2015,9,2]]},"DOI":"10.1517\/13543784.2015.1062873","type":"journal-article","created":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T05:51:24Z","timestamp":1436161884000},"page":"1261-1273","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Focus on ceftazidime-avibactam for optimizing outcomes in complicated intra-abdominal and urinary tract infections"],"prefix":"10.1517","volume":"24","author":[{"given":"David P","family":"Nicolau","sequence":"first","affiliation":[{"name":"Center for Anti-Infective Research and Development Hartford Hospital","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2015,7,6]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.1980.0049"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01009-09"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.6.1211"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.18.4.657-686.2005"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2009.02.021"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00036-08"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12737"},{"key":"e_1_3_3_10_1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3949\/ccjm.80a.12182","article-title":"Carbapenem-resistant Enterobacteriaceae: A menace to our most vulnerable patients","volume":"80","author":"Perez F","year":"2013","unstructured":"Perez F, van Duin D. Carbapenem-resistant Enterobacteriaceae: A menace to our most vulnerable patients. Cleve Clin J Med 2013;80:224\u201333","journal-title":"Cleve Clin J Med"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/249856"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.009142-0"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1086\/529198"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1086\/649554"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e32835635cb"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph6111335"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2014.03.026"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2013.02.031"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt023"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku025"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/23.3.486"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199111000-00001"},{"issue":"1","key":"e_1_3_3_23_1","first-page":"42","article-title":"Diagnosis and management of simple and complicated urinary tract infections (UTIs)","volume":"19","author":"Mazzulli T","year":"2012","unstructured":"Mazzulli T. Diagnosis and management of simple and complicated urinary tract infections (UTIs). Can J Urol 2012;19(Suppl 1):42\u20138","journal-title":"Can J Urol"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1086\/650482"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1086\/668770"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1179\/1973947813Y.0000000121"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874285801206010074"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2014.04.009"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/jhm.2157"},{"key":"e_1_3_3_30_1","article-title":"Demography and burden of care associated with patients readmitted for urinary tract infection","author":"MacVane SH","year":"2014","unstructured":"MacVane SH, Tuttle LO, Nicolau DP. Demography and burden of care associated with patients readmitted for urinary tract infection. J Microbiol Immunol Infect 2014. [Epub ahead of print]","journal-title":"J Microbiol Immunol Infect"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1086\/595011"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks213"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S36140"},{"key":"e_1_3_3_34_1","first-page":"2286","article-title":"Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa","volume":"68","author":"Livermore DM","year":"2013","unstructured":"Livermore DM, Warner M, Mushtaq S. Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa. J Antimicrob Chemother 2013;68:2286\u201390","journal-title":"J Antimicrob Chemother"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt118"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00756-10"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.01.007"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1205073109"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.485979"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01722-10"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.06064-11"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04146-14"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02429-13"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02123-13"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2011.09.012"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1179\/1973947813Y.0000000145"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02894-14"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(03)00065-5"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks468"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01463-13"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00080-14"},{"key":"e_1_3_3_52_1","unstructured":"Nichols W Levasseur P Li J et al. A threshold concentration of avibactam (AVI) during the pharmacokinetic decline phase below which \u03b2-lactamase inhibition in Enterobacteriaceae becomes ineffective. [abstract A-1760]. Paper presented at 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy; 9-12 September 2012; San Francisco California USA"},{"key":"e_1_3_3_53_1","unstructured":"Berkhout J Melchers MJ Van Mill CH et al. Pharmacodynamics of ceftazidime and avibactam in a neutropenic mouse lung model. [abstract A-1022]. Paper presented at 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy; 10-13 September 2013; Denver Colorado USA"},{"key":"e_1_3_3_54_1","unstructured":"Berkhout J Melchers MJ Van Mill CH et al. Exposure response relationship of ceftazidime and avibactam in a neutropenic thigh model. [abstract A-1023]. Paper presented at 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy; 10-13 September 2013; Denver Colorado USA"},{"key":"e_1_3_3_55_1","unstructured":"Li J Knebel W Riggs M et al. Population pharmacokinetic modeling of ceftazidime (CAZ) and avibactam (AVI) in healthy volunteers and patients with complicated intra-abdominal infection (cIAIs). [abstract A-634]. Paper presented at 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy; 9-12 September 2012; San Francisco California USA"},{"key":"e_1_3_3_56_1","unstructured":"Edeki T Armstrong J Li J. Pharmacokinetics of avibactam (AVI) and ceftazidime (CAZ) following separate or combined administration in healthy volunteers. [abstract A-1019]. Paper presented at 53rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; 10-13 September 2013; Denver Colorado USA"},{"key":"e_1_3_3_57_1","unstructured":"Merdjan H Tarral A Haazen W et al. Pharmacokinetics and tolerability of NXL 104 in normal subjects and patients with varying degrees of renal insufficiency [abstract P1598]. Paper presented at 20th European Congress of Clinical Microbiology and Infectious Diseases; 10-13 April 2010; Vienna Austria"},{"key":"e_1_3_3_58_1","unstructured":"Li J Zhou D Nichols W et al. Evaluation of ceftazidime-avibactam (CAZ-AVI) dose regimens for phase III study in patients with different renal function. [abstract A-635]. Paper presented at 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy; 9-12 September 2012; San Francisco California USA"},{"key":"e_1_3_3_59_1","volume-title":"Prescribing Information for Ceftazidime injection","author":"FORTAZ\u00ae","year":"2010","unstructured":"FORTAZ\u00ae. Prescribing Information for Ceftazidime injection. GlaxoSmithKline, LLC; Research Triangle Park, NC: 2010"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-015-0283-9"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01198-10"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03579-14"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00851-12"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03267-14"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02161-13"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.07.023"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks523"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2012.748653"},{"key":"e_1_3_3_69_1","unstructured":"Mazuski JE Gasnik L Armstrong J et al. Efficacy and safety of ceftazidime-avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infection \u2013 results from a Phase III program [abstract 0191]. Paper presented at 25th European Congress of Clinical Microbiology and Infectious Diseases; 25-28 April 2015; Copenhagen Denmark"},{"key":"e_1_3_3_70_1","unstructured":"Carmeli Y Armstrong J Laud P et al. Efficacy and safety of ceftazidime-avibactam and best available therapy in the treatment of ceftazidime-resistant infections \u2013 results from a Phase III study [abstract LBEV0061b]. Paper presented at 25th European Congress of Clinical Microbiology and Infectious Diseases; 25-28 April 2015; Copenhagen Denmark"},{"key":"e_1_3_3_71_1","volume-title":"Performance standards for antimicrobial susceptibility testing; Twentieth informational supplement","author":"Clinical and Laboratory Standards Institute","year":"2010","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; Twentieth informational supplement. M100- S20 Wayne; PA, USA: 2010"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543784.2015.1062873","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T20:35:17Z","timestamp":1770928517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543784.2015.1062873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,6]]},"references-count":69,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9,2]]}},"alternative-id":["10.1517\/13543784.2015.1062873"],"URL":"https:\/\/doi.org\/10.1517\/13543784.2015.1062873","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-07-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}